Tropical Medicine and Infectious Diseases

About Us

The 15th International Conference on Tropical Medicine and Infectious Diseases is a global scientific platform bringing together clinicians, researchers, epidemiologists, microbiologists, public health professionals, infectious disease specialists, and healthcare innovators to explore advances in tropical medicine and infectious disease research. The conference focuses on emerging and re-emerging infections, neglected tropical diseases, antimicrobial resistance, infectious disease diagnostics, vaccine development, epidemiology, and innovative approaches to disease prevention and treatment. With a strong emphasis on scientific collaboration and knowledge exchange, the conference provides opportunities for professionals to present their research, discuss clinical challenges, explore new technologies, and develop collaborations across disciplines.

The event will feature keynote presentations, invited talks, oral presentations, poster sessions, and interactive discussions addressing major global health challenges. Topics will range from tropical infections and vector-borne diseases to One Health, pandemic preparedness, digital health, and equitable access to healthcare.

The 15th edition will be held on July 22–23, 2027, in Amsterdam, Netherlands, bringing together the international scientific community to share knowledge and discuss strategies for improving infectious disease prevention, diagnosis, treatment, and control.

Sessions

Tropical Medicine and Global Health

Advances in tropical medicine, global disease burden, healthcare access, and strategies for improving health outcomes in tropical and resource-limited settings. Discussions will address healthcare disparities, disease prevention programs, international collaboration, and innovative approaches to strengthening healthcare systems. Researchers and healthcare professionals will explore emerging challenges and opportunities in improving global health outcomes.

Emerging and Re-emerging Infectious Diseases

Emerging pathogens, disease outbreaks, novel infections, re-emerging diseases, and advances in surveillance and outbreak response. The session will examine pathogen evolution, outbreak detection, transmission dynamics, and innovative approaches to infectious disease preparedness. Experts will discuss lessons from recent outbreaks and strategies for strengthening global infectious disease surveillance.

Neglected Tropical Diseases

Research and clinical developments in neglected tropical diseases, including disease elimination, preventive chemotherapy, diagnostics, treatment, and community-based interventions. The session will highlight innovations in disease detection, therapeutics, vector control, and integrated approaches to elimination. Special attention will be given to improving access to diagnosis and treatment in vulnerable and underserved populations.

Malaria and Antimalarial Research

Malaria epidemiology, parasite biology, antimalarial drug development, resistance, vaccines, vector control, and elimination strategies. Researchers will present advances in malaria diagnostics, novel therapeutics, vaccine development, and parasite surveillance. The session will also explore strategies for addressing drug resistance and accelerating malaria elimination efforts.

Dengue, Arboviruses and Vector-Borne Diseases

Dengue, chikungunya, Zika, yellow fever, and other vector-borne infections, including mosquito surveillance, vector control, diagnostics, and climate-related disease transmission. The session will explore advances in vector management, pathogen surveillance, clinical diagnosis, and disease prevention. Experts will also examine changing transmission patterns and innovative approaches to controlling arboviral diseases.

Infectious Disease Epidemiology and Surveillance

Disease surveillance, epidemiological modeling, outbreak investigation, genomic epidemiology, public health intelligence, and evidence-based infectious disease control. The session will focus on modern surveillance systems, data-driven outbreak detection, and approaches to understanding disease transmission. Researchers will discuss the use of epidemiological data to support timely public health interventions and decision-making.

Antimicrobial Resistance and Stewardship

Antimicrobial resistance, antibiotic stewardship, resistant pathogens, novel antimicrobial therapies, infection prevention, and strategies for preserving antimicrobial effectiveness. Discussions will address mechanisms of resistance, antimicrobial development, stewardship programs, and surveillance of resistant organisms. The session will explore multidisciplinary approaches to reducing inappropriate antimicrobial use and improving treatment outcomes.

Vaccines, Immunization and Immunotherapy

Vaccine development, immunization programs, vaccine platforms, vaccine effectiveness, immunological responses, and innovative approaches to infectious disease prevention. The session will cover next-generation vaccines, novel vaccine technologies, immunization strategies, and advances in infectious disease immunotherapy. Experts will also discuss vaccine access, effectiveness, safety monitoring, and strategies for improving global immunization coverage.

Infectious Disease Diagnostics and Molecular Microbiology

Rapid diagnostic technologies, molecular diagnostics, pathogen detection, microbiological testing, point-of-care diagnostics, and laboratory innovation. The session will highlight advances in PCR, sequencing, biomarker discovery, rapid testing, and emerging diagnostic platforms. Researchers will discuss how faster and more accurate diagnostics can support early treatment and effective outbreak management.

Viral, Bacterial, Fungal and Parasitic Infections

Advances in the pathogenesis, diagnosis, treatment, and prevention of viral, bacterial, fungal, and parasitic infections, including clinically significant infectious diseases. The session will provide a multidisciplinary platform for discussing pathogen biology, host-pathogen interactions, therapeutic development, and clinical management. New research findings and innovative approaches to controlling infectious diseases will be presented.

One Health and Zoonotic Diseases

Interactions between human, animal, and environmental health; zoonotic disease transmission; antimicrobial resistance; and integrated approaches to infectious disease prevention. The session will examine diseases transmitted between animals and humans and the environmental factors influencing their spread. Experts will discuss collaborative One Health strategies involving medicine, veterinary science, environmental research, and public health.

Tuberculosis, HIV/AIDS and Hepatitis

Research and clinical developments in tuberculosis, HIV/AIDS, viral hepatitis, disease prevention, treatment, drug resistance, and strategies for improving long-term patient outcomes. The session will explore advances in diagnostics, therapeutic approaches, prevention programs, and management of drug-resistant infections. Discussions will also address barriers to disease elimination and improving access to healthcare and treatment.

Climate Change and Infectious Disease

The influence of climate change, environmental disruption, urbanization, and changing ecosystems on infectious disease transmission and public health. The session will examine how temperature, precipitation, environmental changes, and population movement can influence infectious disease patterns. Researchers will discuss climate-informed surveillance, predictive modeling, adaptation strategies, and approaches to reducing climate-related health risks.

Pandemic Preparedness and Global Health Security

Preparedness and response to infectious disease outbreaks, health system resilience, public health emergency management, and international collaboration. The session will address outbreak preparedness, rapid response systems, surveillance networks, emergency planning, and development of resilient healthcare systems. Experts will explore lessons from previous outbreaks and strategies for strengthening future global health security.

Digital Health, Artificial Intelligence and Innovation in Infectious Diseases

AI-assisted diagnostics, digital epidemiology, telemedicine, data science, digital surveillance, precision infectious disease medicine, and emerging technologies in global health. The session will explore how artificial intelligence and digital technologies can support disease prediction, diagnosis, surveillance, and clinical decision-making. Researchers and technology professionals will discuss emerging digital solutions for improving infectious disease research, prevention, and patient care.

Market Analysis

The tropical medicine and infectious diseases market continues to evolve due to the persistent burden of infectious diseases, emerging and re-emerging pathogens, antimicrobial resistance, vector-borne diseases, and the need for improved prevention and treatment strategies. Growing investment in vaccines, therapeutics, molecular diagnostics, disease surveillance, and public health infrastructure is creating opportunities for pharmaceutical, biotechnology, diagnostics, healthcare technology, and research organizations. Neglected tropical diseases also remain an important global health priority, with the World Health Organization reporting that approximately 1.5 billion people required interventions for neglected tropical diseases in 2023.

Technological developments are further transforming the infectious disease landscape through artificial intelligence, genomic surveillance, rapid diagnostic platforms, digital epidemiology, and advanced vaccine technologies. Climate change, urbanization, population mobility, and zoonotic disease transmission are also increasing the need for integrated One Health approaches and stronger outbreak preparedness. These developments are expanding opportunities for collaboration among clinicians, researchers, public health agencies, pharmaceutical and biotechnology companies, diagnostic organizations, and academic institutions, making tropical medicine and infectious disease research an important area for continued scientific and healthcare innovation.

Past Conference Report

Tropical Diseases 2025

The 14th International Conference on Tropical Medicine and Infectious Diseases brought together professionals from tropical medicine, infectious diseases, microbiology, epidemiology, public health, and related healthcare disciplines to discuss advances in infectious disease research and global health. The conference provided an international platform for the exchange of scientific knowledge, clinical experiences, and research findings related to tropical diseases and infectious disease prevention. Participants discussed the continuing challenges associated with emerging infections, neglected tropical diseases, antimicrobial resistance, diagnostic innovation, and disease surveillance.

The event also highlighted the importance of collaboration between academic researchers, healthcare professionals, public health organizations, and industry representatives in addressing infectious disease challenges. Presentations and scientific discussions covered advances in disease diagnosis, treatment, prevention, and healthcare innovation. The conference encouraged researchers and professionals to share their findings, develop new collaborations, and explore approaches to improving infectious disease control and patient care.

The successful completion of the 14th edition provided a foundation for continued scientific exchange and international collaboration. The upcoming 15th International Conference on Tropical Medicine and Infectious Diseases will build on this platform by bringing together professionals to discuss emerging scientific developments, innovative healthcare solutions, and future directions in tropical medicine and infectious disease research.